Genomics is a traditional concept with traces of genome market traced back right from 1926 when a geneticist at the Jackson Laboratory Tom Roderick, coined the term genomics. In 1981, the 1st complete genome sequence of the human mitochondrion (16.6 kb), was registered. Then in 2003 the accomplishment of the Human Genome Project, sequencing of 3.2 billion base pairs of a DNA that make up the human genome, which took many years and cost hefty amounts of time and capital was completely sequenced, with every single human gene sequences were accessible in the public domain.
Get more details @ http://bit.ly/2poGpMf Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.
Global Digital Genome Market Information by Disease (cancer, diabetes), by End users hospitals, research laboratories) by application (diagnostics, drug discovery, academic research) - Forecast to 2027
Market Industry Reports (MIR) has published a new report titled “Genome Editing/Genome Engeineering Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report the global genome editing market was valued at over US$ 3.0 Bn. in 2017 and is expected to grow at a double digit CAGR during the forecasted period. The growth of this market can be attributed to the major factor that is utilization of the technique for therapeutic genetic editing in infected tissues and cells, thereby reducing the mutations.
Get more details @ http://bit.ly/2nUpHlT Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.
Goldstein Research analyst forecast the digital genome market size is set to reach USD 24.3 billion by 2025, at a CAGR of 8.78% over the forecast years
Get more details @ http://bit.ly/2nUpHlT Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.
Single User License: US $2500; Buy the Report @ http://www.sandlerresearch.org/purchase?rname=44172 Alternatively can get Discount on the Report @ http://www.sandlerresearch.org/discount?rname=44172
The global digital biomanufacturing market report highlights that the market was valued at $15,768.9 million in 2021 and is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031.
Market Overview: Cancer Tissue Diagnostics Market Cancer tissue diagnostics play a pivotal role in oncology by facilitating accurate diagnosis, prognosis, and treatment selection based on tissue samples obtained from patients. The global cancer tissue diagnostics market is witnessing steady growth, driven by the increasing incidence of cancer, advancements in diagnostic technologies, and growing emphasis on personalized medicine.
In 2017, the global Digital Health market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was estimated at $4876 million in 2020, and is projected to grow at a CAGR of 9.2% during the forecast period 2021-2026.
On the basis of type of application, the global digital PCR and qPCR market is classified into research applications, clinical applications, and forensic applications
Get Sample Brochure of Report @ http://www.marketintelreports.com/pdfdownload.php?id=9dime5731 The report includes detailed analysis on Digital PCR Devices market segmentation, global notable vendors, geographical outlook, price & financial updates, segment & application approach and future forecasts.
The global qPCR and dPCR market is expected to reach USD 4.94 Billion by 2021 from USD 3.28 Billion in 2016, growing at a CAGR of 8.5% from 2016 to 2021.
This report studies the global digital PCR (dPCR) and qPCR market over the forecast period of 2014 to 2019. The market is expected to reach $3.97 billion by 2019, at CAGR of 7.8% from 2014 to 2019.
Digital health is the convergence of digital and genomic technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and make medicines more personalized and precise. The discipline involves the use of information and communication technologies to help address the health problems and challenges faced by patients
Global single-cell analysis market is set to witness a healthy CAGR of 17.5% in the forecast period of 2019 to 2026. The report contains data of the base year 2018 and historic year 2017. This rise in the market can be attributed due to increasing adoption of single-cell analysis for diagnostic.
The global qPCR and dPCR market is expected to reach USD 4.94 billion by 2021 from USD 3.28 billion in 2016, growing at a CAGR of 8.5% during the forecast period. Market growth can be attributed to the rising incidences of infectious diseases and genetic disorders (coupled with growing geriatric population that is at greater risk of target diseases as compared to adults); technological advancements; increasing public-private investments, funds, and grants; successful completion of the Human Genome Project, and rise in the number of hospitals and diagnostic centers.
The spatial genomics and transcriptomics market was estimated at $269.6 Million in 2020 and is expected to grow at a CAGR of 23.20% during the forecast period from 2020-2030.
The global digital biomanufacturing market is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031.
The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031.
Market Report Titled "Active Pharmaceutical Ingredients Market Research Report – Forecast to 2023" is a Specialist Examination Report Explores the Market by Research Methodology, Segmentation, Key Players, and Major Region Globally .
The Market Report “Global Assisted Reproductive Technology Market 2018” Offers Vital Insights on every Industry segment in terms of market size analysis for Industry across the different regions.
The global cancer diagnostics market size was USD 175.1 billion in 2021 and is projected to grow at a CAGR of 7.2% to reach USD 305.3 billion by 2030. The Cancer Diagnostics Market is a rapidly evolving sector at the forefront of the global healthcare industry. Advancements in technology and increasing cancer prevalence drive market growth. Diagnostic methods like imaging, genomics
"AI in Social Media market" In the genomics industry, highlighting higher level geographies and breaking down significant business sectors allows for in-depth study of market data. The study strikes the ideal balance between qualitative and quantitative data about the global market for AI in Social Media market.
The global multiplex assays market is expected to register a CAGR of 8.12% during 2024-2032 and reach a revenue of $7793.26 million by 2032. Get more insights
The global artificial intelligence (AI) in epidemiology market is set to grow with a 27.33% CAGR between 2024 and 2032. Get more insights into our latest blogs
"Content Services Platforms market" In the genomics industry, highlighting higher level geographies and breaking down significant business sectors allows for in-depth study of market data. The study strikes the ideal balance between qualitative and quantitative data about the global market for Content Services Platforms market.
"Telecom System Integration market" In the genomics industry, highlighting higher level geographies and breaking down significant business sectors allows for in-depth study of market data. The study strikes the ideal balance between qualitative and quantitative data about the global market for Telecom System Integration market.
A newly published report by Market Statsville Group (MSG), title dGlobal Pharmacogenomics Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global Pharmacogenomics market will showcase an impressive CAGR from 2024 to 2033. The comprehensive Pharmacogenomics market research study highlights market dynamics, value chain analysis, regulatory framework, growing investment hotspots, competitive landscape, geographical landscape, and extensive market segments.
The global pharmaceutical market is valued at approximately $1.2 trillion. Projections indicate sustained growth, with estimates anticipating a market value exceeding $1.5 trillion by 2025. The pharmaceutical market growth rate underscores its resilience and pivotal role in global healthcare.
The Global Biochips Market size is expected to reach $20.3 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period. Biochips are miniaturized medical devices used within molecular laboratories to conduct simultaneous biochemical reactions. These devices can rapidly screen multiple biological analytes for several applications like disease diagnosis and identification of hazardous biological agents existing in systems. Their design is based on microarray and microfluidic technologies. Among the two, digital microfluidic biochip has surfaced as a highly efficient chip and has gained huge traction in the biochemical industry. Full Report: https://www.kbvresearch.com/biochips-market/
A newly published report by Market Statsville Group (MSG), titled Global Prime Editing and CRISPR Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global Prime Editing and CRISPR market will showcase an impressive CAGR from 2024 to 2033.
In Vitro Diagnostics Market USD 102.18 billion in 2024, poised for significant growth to USD 131.66 billion by 2029, with a notable CAGR of 5.20%. The catalyst for this growth is the global response to the COVID-19 pandemic.
This has fueled the significant growth of the nutritional and dietary supplements market, estimated at a colossal $137.5 billion in 2023, and projected to reach a staggering $227.3 billion by 2030, with a robust CAGR of 7.6%.
According to the Market Statsville Group (MSG), the global laboratory robotics market size is expected to grow from USD 209.55 million in 2022 to USD 406.13 million by 2033, growing at a CAGR of 6.2% from 2023 to 2033.
The global metagenomics sequencing market size was valued at USD 974.3 million in 2020 and is expected to reach USD 2,564.01 million by 2027, with a CAGR of 17.5% during the forecast period.
According to the Market Statsville Group (MSG), the U.S. esoteric testing market size is estimated to grow USD 9.5 billion by 2030 from USD 5.7 billion in 2021, at a CAGR of 6.7% from 2022 to 2030.
Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision), Application, End User and Region - Global Forecast to 2028
The AI in Healthcare Market size is projected to grow from USD 14.6 Billion in 2023 to USD 102.7 Billion by 2028; it is expected to grow at a CAGR of 47.6% during the forecast period.
According to the Market Statsville Group (MSG), the global next generation sequencing market size is expected to grow from USD 9,345.0 million in 2022 to USD 58,254.4 million by 2033, at a CAGR of 18.1% from 2023 to 2033.